NSEESOP/ESOS/ESPS6d ago · 13 Aug 2026, 08:26 pm

ESOP/ESOS/ESPS

Banka BioLoo Limited · BANKA

✦ AI SummaryESG

Banka BioLoo Limited has informed the Exchange regarding the grant of 16,000 options under the Banka BioLoo Limited Employees Stock Option Plan - 2023.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Banka BioLoo Limited has informed the Exchange regarding Grant of 16000 Options.

Attachments (1)

📄

BANKA_13082026202524_ESOPGrantdisclosure.pdf

pdf

Download →
View document text
BANKA BIOLOO LIMITED Registered Office: A-109 Express Apartments, Lakdi ka Pool, Hyderabad - 500004 Corporate Office: 5th floor, Prestige Phoenix, 1405, Uma Nagar, Begumpet, Hyderabad - 500016 +91 8688825013 • info@bankabio.com • www.bankabio.com • CIN: L90001TG2012PLC082811 An ISO 9001-2015-14001-2015-45001-2018 Company BBL/ SECT/22/2026-27 Date: 13 August 2026 The Listing Department National Stock Exchange of India Limited, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 NSE Symbol: BANKA Dear Sir/Madam, Sub: Grant of Options under the Banka BioLoo Limited Employees Stock Option Plan - 2023 Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform that the Nomination and Remuneration Committee of the Board of Directors of the Company (“NRC”), at their meeting held on today i.e., Thursday, 13 August 2026, has approved the grant of 16,000 (Sixteen Thousand) Options under the Banka BioLoo Limited Employees Stock Option Plan – 2023 (“Scheme”). The disclosure pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, and in accordance with Regulation 30 of the SEBI Listing Regulations is annexed as Annexure 1. The above information will also be available at the website of the Company www.bankabio.com. We request you to kindly take note of the same in your record. Thank you, For Banka BioLoo Limited Manjula Chunduru Company Secretary & Compliance Officer Encl: As above Annexure 1 Particulars Details Brief details of options granted 16,000 (Sixteen Thousand) Options granted to the eligible employees of the Company under the Banka BioLoo Limited Employees Stock Option Plan – 2023 (“Scheme”) Whether the scheme is in terms of SEBI Yes, the scheme is in compliance with the SEBI (SBEBASE) Regulations, 2021 (if (SBEB & SE) Regulations, 2021. applicable) Total number of shares covered by these 16,000 (Sixteen Thousand) Options granted shall options be exercisable into 16,000 (Sixteen Thousand) Equity Shares of face value Rs.10/- (Rupee Ten) each. Pricing Formula At face value i.e. Rs.10/- (Rupee Ten) each Options vested Not Applicable Vesting schedule The options would vest in the following manner: i. Upon completion of 12 calendar months from the date of grant; 25% of the Options shall vest; ii. Upon completion of 24 calendar months from the date of grant; 25% of the Options shall vest; iii. Upon completion of 36 calendar months from the date of grant; 25% of the Options shall vest; iv. Upon completion of 48 calendar months from the date of grant; 25% of the Options shall vest; Time within which option may be The Options granted can be exercised by the exercised eligible employee within 2 years from the date of vesting of options. Options exercised Not Applicable Money realized by exercise of options Not Applicable The total number of shares arising as a Not Applicable result of exercise of option Options lapsed Not Applicable Variation of terms of options Not Applicable Brief details of significant terms  The terms of the grant of options, provides for the manner in which options would be dealt with, in case of death, permanent incapacity, resignation, termination, retirement, abandonment, etc.  The equity shares allotted, pursuant to the exercise of the stock options, would not be subject to lock-in.  ESOP Shares arising on the conversion of the Options shall rank pari passu with all the other equity Shares of the Company for the time being in issue, from the date of allotment. Subsequent changes or cancellation or Not Applicable exercise of such options Diluted earnings per share pursuant to Not Applicable issue of equity shares on exercise of options.